-
March 2012 Update: Generic Drug Manufacturers Immunity By Means Of Mensing Preemption Ruling
One Year After The Hearing In Pliva v. Mensing, Some Momentum Builds For (Once Again) Allowing Drug Injury Lawsuits On All Prescription Medications, Generic As Well As Brand Name (Posted by Tom Lamb at…
-
Focus on Pradaxa Pradaxa® is the name under which Boehringer Ingelheim Pharmaceuticals, Inc. markets a prescription anticoagulant medication generically called dabigatran. _______________________________________________________________________________ Free Pradaxa Case Evaluation The information you provide to us for…
-
Pradaxa: 2012 Label Revisions In The U.S. And Canada, Where A “Dear Doctor” Letter Was Sent Out
New Case Report About Routine Fall Involving An Elderly Patient That Results In Fatal Irreversible Brain Hemorrhage (Posted by Tom Lamb at DrugInjuryWatch.com) Pradaxa® is the name under which Boehringer Ingelheim Pharmaceuticals, Inc. markets a prescription…
-
950 NuvaRing Lawsuits Pending As Of December 31, 2011 According To Merck Annual Report
820 Cases Are Filed In Federal Court NuvaRing MDL And 125 Lawsuits Are Part Of New Jersey State Court Mass Tort (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: First NuvaRing Lawsuit Trials Against Merck Are…
-
Current First NuvaRing Trial Date: New Jersey State Court Bellwether Case Set For Early February 2013
Federal Court NuvaRing MDL Bellwether Trial Dates Pushed Back Several Times Previously; Perhaps It Will Be Late 2012 (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ Judge Rodney Sippel's October 8, 2013 Order Rescheduling First NuvaRing…
